Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography
- PMID: 25798930
- PMCID: PMC4370392
- DOI: 10.1371/journal.pone.0121601
Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography
Abstract
Objective: To investigate the role of contrast-enhanced ultrasonography (CEUS) and Doppler ultrasonography (DUS) in the diagnosis of severe portal hypertension (PH) in patients with liver cirrhosis (LC).
Methods: Patients with PH scheduled to receive hepatic venous pressure gradient (HVPG) measurement were recruited for this study. Hepatic DUS and CEUS were performed successively. Several Doppler and CEUS parameters were explored for correlation with HVPG values and their association with severe PH (≥ 12 mmHg of HVPG). Comparison of the parameters between the severe and non-severe PH groups and their correlation with HVPG values was evaluated. A receiver operating characteristic (ROC) curve analysis was also performed to investigate the performance in order to diagnose severe PH.
Results: Fifty-three consecutive patients were enrolled in this study. Among them, 43 patients did not have significant ascites. Compared with the non-severe PH group, portal venous velocity and intrahepatic transit time (ITT) were significantly reduced in the severe PH group (all p<0.05). Difference between inspiratory and expiratory hepatic venous damping indices (ΔHVDI), hepatic venous arrival time (HVAT) and ITT moderately correlated with HVPG (r = -0.358, -0.338, and -0.613, respectively). Areas under the curves for severe PH were 0.94 of ITT and 0.72 of HVAT, respectively (all p<0.05). ITT under 6 seconds indicated severe PH with a sensitivity of 92% and a specificity of 89%.
Conclusions: Hepatic CEUS may be more useful in estimating the HVPG value and determining the presence of severe PH compared to DUS, and ITT was the most accurate parameter to diagnose severe PH.
Conflict of interest statement
Figures




Similar articles
-
Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis.Hepatology. 2012 Sep;56(3):1053-62. doi: 10.1002/hep.25752. Epub 2012 Jul 12. Hepatology. 2012. PMID: 22473911
-
Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.Liver Int. 2007 Oct;27(8):1103-10. doi: 10.1111/j.1478-3231.2007.01526.x. Liver Int. 2007. PMID: 17845539 Clinical Trial.
-
[Clinical value of contrast-enhanced ultrasound in evaluating portal hypertension in patients with decompensated liver cirrhosis].Zhonghua Gan Zang Bing Za Zhi. 2016 Apr;24(4):270-4. doi: 10.3760/cma.j.issn.1007-3418.2016.04.006. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27470625 Chinese.
-
Non-invasive evaluation of liver cirrhosis using ultrasound.Clin Radiol. 2009 Nov;64(11):1056-66. doi: 10.1016/j.crad.2009.05.010. Epub 2009 Aug 14. Clin Radiol. 2009. PMID: 19822238 Review.
-
Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography.Hepatol Int. 2016 Mar;10(2):267-76. doi: 10.1007/s12072-015-9670-9. Epub 2015 Dec 22. Hepatol Int. 2016. PMID: 26696585 Review.
Cited by
-
Ultrasonography for Noninvasive Assessment of Portal Hypertension.Gut Liver. 2017 Jul 15;11(4):464-473. doi: 10.5009/gnl16078. Gut Liver. 2017. PMID: 28267700 Free PMC article. Review.
-
Diagnostic accuracy of the attenuation value in abdominal contrast enhanced dynamic multi-detector-row computed tomography for esophageal varices in patients with liver cirrhosis.Eur J Radiol Open. 2021 Apr 23;8:100347. doi: 10.1016/j.ejro.2021.100347. eCollection 2021. Eur J Radiol Open. 2021. PMID: 33997144 Free PMC article.
-
Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study.Gut Liver. 2018 Sep 15;12(5):555-561. doi: 10.5009/gnl17342. Gut Liver. 2018. PMID: 29699059 Free PMC article.
-
Application of Contrast-Enhanced Ultrasound Combined with Elastic Imaging Technology in Differential Diagnosis of Salivary Gland Tumors.J Healthc Eng. 2022 Apr 12;2022:4600751. doi: 10.1155/2022/4600751. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Oct 11;2023:9862578. doi: 10.1155/2023/9862578. PMID: 35449870 Free PMC article. Retracted.
-
Contrast-enhanced ultrasonography of the hepatic vein in normal dogs.J Vet Med Sci. 2017 Jan 10;78(12):1753-1758. doi: 10.1292/jvms.16-0062. Epub 2016 Aug 18. J Vet Med Sci. 2017. PMID: 27534912 Free PMC article.
References
-
- Seitz K, Bernatik T, Strobel D, Blank W, Friedrich-Rust M, Strunk H, et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI—a prospective comparison in 269 patients. Ultraschall Med. 2010;31: 492–499. 10.1055/s-0029-1245591 - DOI - PubMed
-
- Strobel D, Seitz K, Blank W, Schuler A, Dietrich CF, von Herbay A, et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med. 2009;30: 376–382. 10.1055/s-0028-1109672 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical